BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AGAH - ECPv5.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AGAH
X-ORIGINAL-URL:https://dev.agah.eu
X-WR-CALDESC:Veranstaltungen für AGAH
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190124
DTEND;VALUE=DATE:20190126
DTSTAMP:20260929T014151
CREATED:20190523T072025Z
LAST-MODIFIED:20210608T091240Z
UID:2433-1548288000-1548460799@dev.agah.eu
SUMMARY:Implementation of translational approaches
DESCRIPTION:AGAH-Workshop on the implementation of TRANSLATIONAL APPROACHES to support dose selection and dose escalation schemes in early clinical trials\n\n\n\n	CONTENT\nSelecting the adequate starting dose and defining appropriate dose escalation schemes in early clinical trials? A real challenge! Therefore\, this workshop has been developed to specifically address translational aspects from the non-clinical to the clinical phase allowing for unique and detailed insight in a highly interactive manner between participants. A team of experienced experts including from industry\, CROs\, regulatory authorities\, ethical review committees and investigators has put together a program which is entirely based on real examples. These case studies will be discussed step-by-step on the grounds of the recently revised European Guideline on Strategies to Identify and Mitigate Risks for First-In-Human and Early Clinical Trials with Investigational Medicinal Products. \nEach case study will be presented and discussed to guide you through the following topics: \n\n1. The non-clinical basis\, including Pharmacology\, DMPK and Toxicology\n2. Translational modelling from non-clinical to clinical studies\n3. And finally\, the integration of the clinical outcome: reality check and refinement/lessons learned – has it worked?\n\nThis workshop will provide an excellent opportunity to foster a broader understanding of translational approaches and is designed for participants from regulatory agencies\, industry\, ethical review committees\, academia and for investigators. \nOver the last years\, AGAH has been organising as series of workshops and discussion forums to address the events in Rennes and to contribute to the revision of the European FIH guideline. This upcoming workshop is in line with these earlier activities. It will focus on how to implement translational approaches from a practical perspective to design early clinical trials and to assess their adequacy and significance.\n\n\n\n\n	DOWNLOADS \nProgramm: Implementation Translational Approaches \n  \nDobrzanski Pawel\nDo we need to know the mechanism of action: the pitfalls and rewards of targeting chitinases \nSudhop Thomas\nKey considerations regarding dose escalation schemes in FIH and early clinical trials  \nMueller Lutz\nRisdiplam: Editing on the RNA level – a dream or a nightmare? Spinal Muscular Atrophy as example \nStahl Elke\nRevision of the ‚first in human‘ guideline \nDembowsky Klaus - no presentation available\nAMC303: a peptide based CD44v6 inhibitor for cancer therapy
URL:https://dev.agah.eu/event/implementation-of-translational-approaches/
LOCATION:AGAH Workshop\, Bonn\, Deutschland
END:VEVENT
END:VCALENDAR